Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 5;31(12):1741-1759.e8.
doi: 10.1016/j.stem.2024.09.013. Epub 2024 Oct 18.

Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming

Affiliations
Free article

Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming

Yi-Ru Shen et al. Cell Stem Cell. .
Free article

Abstract

Yamanaka factors (YFs) can reverse some aging features in mammalian tissues, but their effects on the brain remain largely unexplored. Here, we induced YFs in the mouse brain in a controlled spatiotemporal manner in two different scenarios: brain development and adult stages in the context of neurodegeneration. Embryonic induction of YFs perturbed cell identity of both progenitors and neurons, but transient and low-level expression is tolerated by these cells. Under these conditions, YF induction led to progenitor expansion, an increased number of upper cortical neurons and glia, and enhanced motor and social behavior in adult mice. Additionally, controlled YF induction is tolerated by principal neurons in the adult dorsal hippocampus and prevented the development of several hallmarks of Alzheimer's disease, including cognitive decline and altered molecular signatures, in the 5xFAD mouse model. These results highlight the powerful impact of YFs on neural proliferation and their potential use in brain disorders.

Keywords: Alzheimer’s disease; DNA methylation; Yamanaka factor; cortex expansion; neurodegeneration; neurogenesis; rejuvenation; reprogramming; synapses.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests M.S. is a shareholder of Senolytic Therapeutics, Life Biosciences, Rejuveron Senescence Therapeutics, and Altos Labs. M.S. was a consultant of Rejuveron Senescence Therapeutics and Altos Labs until the end of 2022. M.A. is a shareholder of Altos Labs.

LinkOut - more resources